New Retina Radio by Eyetube

191 Folgen

1. New Retina Radio Journal Club: Recurrent RRD Management

   Vom: 14.7.2022
2. The Life and Career of Steve Charles, MD, FACS, FICS, FASRS

   Vom: 30.6.2022
3. New Retina Radio Journal Club: Pentosan Polysulfate Maculopathy

   Vom: 23.6.2022
4. ARVO Meeting Coverage Day 3: CANDELA and ARCHWAY Data

   Vom: 9.6.2022
5. ARVO Meeting Coverage Day 2: Pipeline Therapies in GA

   Vom: 2.6.2022
6. ARVO Meeting Coverage Day 1: LIGHTSITE III and DERBY/OAKS at 18 Months

   Vom: 26.5.2022
7. New Treatment Options and Considerations for AMD

   Vom: 19.5.2022
8. New Retina Radio Journal Club: Trends in Retina Reimbursement

   Vom: 12.5.2022
9. New Retina Radio Journal Club: Diversity in Clinical Trials

   Vom: 21.4.2022
10. New Retina Radio Journal Club: PPV vs PnR for RRD

    Vom: 31.3.2022
11. Art of Drug Choice: Treating New Wet AMD Patients

    Vom: 24.3.2022
12. Art of Drug Choice: Who Is Best Suited for Extended-duration Therapy?

    Vom: 17.3.2022
13. Art of Drug Choice: The Latest Advances in Wet AMD Therapy

    Vom: 3.3.2022
14. Anti-VEGF, A Biography: Part 3

    Vom: 24.2.2022
15. Anti-VEGF, A Biography: Part 2

    Vom: 17.2.2022
16. Exploring the clinical development program for an innovative, continuous delivery treatment for nAMD

    Vom: 11.2.2022
17. Tackling PVR in the OR

    Vom: 3.2.2022
18. Anti-VEGF, A Biography: Part 1

    Vom: 27.1.2022
19. Perspectives on an innovative drug delivery system for nAMD: From training to initial experiences

    Vom: 18.1.2022
20. Matching Patients to Therapy in Wet AMD: Lifestyle Factors That Guide Treatment

    Vom: 4.1.2022